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Abstract
Objectives Dual energyX-ray absorptiometry (DXA) is themost
widely used technique to measure bone mineral density (BMD).
Appropriate and accurate use of DXA is of great importance, and
several guidelines have been developed in the last years. Our aim
was to evaluate the quality of published guidelines on DXA for
adults.
Methods Between June and July 2016 we conducted an on-
line search for DXA guidelines, which were evaluated by four
independent readers blinded to each other using the AGREE II
instrument. A fifth independent reviewer calculated scores per
each domain and agreement between reviewers’ scores.
Results Four out of 59 guidelines met inclusion criteria and
were included. They were published between 2005 and 2014.
Three out of four guidelines reached a high level of quality,
having at least five domain scores higher than 60%. Domain 1
(Scope and Purpose) achieved the highest result (total
score = 86.8 ± 3.7%). Domain 6 (Editorial Independence)
had the lowest score (total score = 54.7 ± 12.5%).
Interobserver agreement ranged from fair (0.230) to good
(0.702).
Conclusions Overall, the quality of DXA guidelines is satis-
factory when evaluated using the AGREE II instrument. The
Editorial Independence domain was the most critical, thus
deserving more attention when developing future guidelines.
Main messages
• Three of four guidelines on DXA had a high quality level
(>60%).
• Scope/purpose had the highest score (86.8 ± 3.7%).
• Editorial Independence had the lowest score (54.7 ± 12.5%).
• Interobserver agreement ranged from fair (0.230) to good
(0.702).
Keywords Dual-energyX-ray absorptiometry . DXA .
Guidelines . Agree . Evidence basedmedicine
Introduction
Osteoporosis is defined as a systemic skeletal disease
characterised by low bone mass and microarchitectural dete-
rioration of bone tissue, with a subsequent increase in bone
fragility and susceptibility to fracture [1]. Instrumental diag-
nosis of osteoporosis relies on bone mineral measurements,
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which can be obtained in vivo using different densitometric
techniques. Among these, dual energy X-ray absorptiometry
(DXA) is the most widely used in clinical practice [2–4].
Advantages of DXA are the very low radiation dose adminis-
tered to patients, its very good reproducibility, and the capa-
bility to provide bonemineral density (BMD) values at central
sites that relate to fracture risk [3, 5]. Other available tech-
niques include quantitative ultrasound (QUS) and quantitative
computed tomography (QCT) [6].
Appropriate and accurate use of densitometric techniques
is of great importance: bone mineral measurements provide
not only diagnostic criteria but also prognostic information on
fracture risk probability, and they are also used to monitor
treated or untreated patient [6]. For this reason, several guide-
lines have been developed in the last years with a number of
recommendations that include indications for BMD testing,
which skeletal site to measure, how to interpret and report
BMD results, and proper timing for follow-up [7–10]. These
guidelines, typically issued by relevant medical societies or
specialised working groups, play an important role in clinical
practice: they provide valuable suggestions based on the
highest level of evidence, which is usually achieved through
a critical evaluation of systematically searched primary studies
[11, 12]. Nevertheless, clinical guidelines may vary widely in
quality; as a consequence, it is important to evaluate the
methods on which a guideline was developed in order to be
confident with its recommendations [13, 14]. To do this, dif-
ferent quality appraisal instruments have been developed for
evaluating guidelines. Among these, the Appraisal of
Guidelines for Research & Evaluation version II (AGREE
II) is reported to be a reliable, internationally used and vali-
dated tool [15].
The European Network for the Assessment of Imaging in
Medicine European Institute for Biomedical Imaging Research
(EuroAIM) was initiated with the aim to increase the evidence
for the rational use of imaging technology [12, 16]. Currently,
EuroAIM focused its attention on the evaluation of guidelines in
different fields of diagnostic imaging. Regardingmusculoskeletal
radiology, a conjoined project between EuroAIM and the
European Society of Musculoskeletal Radiology (ESSR) was
established. DXA and densitometric techniques were included
among the topic of interests. Therefore, the aim of this study is
to evaluate the quality of current guidelines on DXA for adults
using the AGREE II quality assessment tool.
Materials and methods
Between June and July 2016 we searched for DXA
guidelines using PubMed, EMBASE, Google and the
Wiley Online Library, using the following keywords:
Bdual energy X-ray absorptiometry ,^ BDXA^, BDEXA^,
Bbone densitometry ,^ BGuidelines^, BOfficial Positions^,
BOsteoporosis^ and their expansions. Once guidelines
had been retrieved, their references were also screened
for further papers to include. We excluded from the
results of our search those papers that were not primar-
ily focused on DXA, such as national/international os-
teoporosis guidelines in which DXA was briefly men-
tioned in the context of a more comprehensive disease
evaluation. Inclusion criteria were as follows: guidelines
issued by national and international medical societies;
full-manuscript available in English; guidelines must
mainly contain recommendation on DXA, irrespective
of other densitometric techniques; guidelines must focus
mainly on the adult population (age >18 years).
The evaluation of guideline quality was made using the
AGREE II instrument through the official website dedicated on-
line platform [15]. The AGREE II protocol consists of 23 differ-
ent items organised in 6 domains: domain 1 = BScope and
Purpose^ (items 1–3); domain 2 = BStakeholder Involvement^
(items 4–6); domain 3 = BRigor of Development^ (items 7–14);
domain 4 = BClarity of Presentation^ (items 15–17); domain
5 = BApplicability^ (items 18–21); domain 6 = BEditorial
Independence^. These six domains are followed by two addi-
tional items (BOverall Assessment^), which includes Bthe rating
of the overall quality of the guideline and whether the guideline
would be recommended for use in practice^. Table 1 shows a
detailed description of all AGREE II items [15].
Four independent reviewers (CM, BB, AB, CMP) with 4 to
15 years’ experience in musculoskeletal radiology and scientif-
ic research scored each guideline. All reviewers were previous-
ly trained to use AGREE II rating system by means of the user
manual that was available on the online platform; in addition,
reviewers were asked to complete two online training tools
specifically developed to assist users in effectively applying
the instrument. According to instruction tool, each item was
rated on a 7-point scale ranging from 1 (strongly disagree,
which means that no relevant information is provided) to 7
(strongly agree, which means that the quality of reporting is
exceptional). Final domain scores were calculated by summing
up all item scores within the domain and by scaling the total as a
percentage of themaximum possible score for that domain [15].
Data analysis
For analysis purposes, the evaluations performed by the four
reviewers were averaged, and the average of each domain is
reported in the results. Agreement between reviewers’ scores
was calculated using the intraclass correlation coefficient (ICC),
defined as follows: <0.20, poor; 0.21–0.40, fair; 0.41–0.60, mod-
erate; 0.61–0.80, good; 0.81–1.00, very good. As for previous
studies, the overall quality of each guidelines was evaluated
using a threshold of 60% for the final score of each domain
[17, 18]. High quality was defined when 5 or more domains
scored >60%, average quality when 3 or 4 domains scored
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>60% and low-quality when ≤2 domains scored >60%. In addi-
tion, the total score (expressed asmean ± standard deviation, SD)
of guidelines and domains was calculated. Domain scores were
categorised as good (≥80%), acceptable (60–79%), low (40–
59%) or very low (<40%), similar to a previous similar paper
[19]. Data collection, extraction and scoringwere performed by a
fifth independent reviewer (LMS)with 12 years’ experience in in
musculoskeletal radiology and scientific research, using a
Microsoft Excel® 2016 spreadsheet. ICC calculations were
performed using the SPSS software (version 24, IBM,
Armonk, NY).
Results
Our strategy of literature search identified 59 guidelines, 4 of
which met our inclusion criteria [7–10]. Exclusion of guide-
lines was mainly based on the following criteria: guidelines
Table 1 Summary of AGREE II
structure and detailed list of items
within each domain (from
reference 15)
Domain 1. Scope and Purpose
Item 1 The overall objective(s) of the guideline is (are) specifically described
Item 2 The health question(s) covered by the guideline is (are) specifically described
Item 3 The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described
Domain 2: Stakeholder Involvement
Item 4 The guideline development group includes individuals from all the relevant professional
groups
Item 5 The views and preferences of the target population (patients, public, etc.) have been
sought
Item 6 The target users of the guideline are clearly defined
Domain 3: Rigor of Development
Item 7 Systematic methods were used to search for evidence
Item 8 The criteria for selecting the evidence are clearly described
Item 9 The strengths and limitations of the body of evidence are clearly described
Item
10
The methods for formulating the recommendations are clearly described
Item
11
The health benefits, side effects and risks have been considered in formulating the
recommendations
Item
12
There is an explicit link between the recommendations and the supporting evidence
Item
13
The guideline has been externally reviewed by experts prior to its publication
Item
14
A procedure for updating the guideline is provided
Domain 4: Clarity of Presentation
Item
15
The recommendations are specific and unambiguous
Item
16
The different options for management of the condition or health issue are clearly
presented
Item
17
Key recommendations are easily identifiable
Domain 5: Applicability
Item
18
The guideline describes facilitators and barriers to its application
Item
19
The guideline provides advice and/or tools on how the recommendations can be put
into practice
Item
20
The potential resource implications of applying the recommendations have been
considered
Item
21
The guideline presents monitoring and/or auditing criteria
Domain 6: Editorial Independence
Item
22
The views of the funding body have not influenced the content of the guideline
Item
23
Competing interests of guideline development group members have been recorded and
addressed
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were primarily focused on a densitometric technique different
from DXA, such as quantitative computed tomography; the
main target was pediatric population; fracture risk assessment
guidelines; body composition guidelines. The characteristics
of DXA guidelines that were included in our study are pre-
sented in Table 2. Year of publication ranged from 2005 to
2014.
Table 3 summarises the total score for each domain as well
as the final judgment of overall quality. Detailed scores and
reviewers’ comments for each guideline are reported in
Supplementary Tables 1, 2, 3 and 4. Three out of four guide-
lines reached a high level of quality, having at least five do-
main scores higher than 60%. Among these, BAdult and
Pediatric Official Positions^ issued by the International
Society for Clinical Densitometry (ISCD) [7] achieved the
highest total score (76.1%). The only guideline that reached
an average level of quality was the one issued conjoinedly by
the American College of Radiology (ACR), the Society for
Pediatric Radiology (SPR) and the Society of Skeletal
Radiology (SSR) [9], with only four domains scoring >60%
and a total score of 64.1% ±11.3% [mean ± standard deviation
(SD)]. ISCDOfficial Position was the guideline with the more
variable scores, with a SD of 18.1%, while the Canadian rec-
ommendation paper [8] had the lowest variability
(SD = 9.5%). Supplementary Tables 1, 2, 3 and 4 show the
detailed AGREE II domain scores for each guideline.
Domain scores ranged between 41.7% (lowest value, do-
main 6 of ISCD Official Positions) and 91.7% (highest value,
domain 1 of ISCD Official Positions). When comparing the
scores of each domain across guidelines, BScope and Purpose^
(domain 1) and BClarity of Presentations^ (domain 4)
achieved the highest results, with a total domain score of
86.8 ± 3.7% and 80.6 ± 9.3%, respectively. The domain with
the lowest total score was BEditorial Independence^
(domain 6), with a total mean score of 54.7 ± 12.5%.
Total mean score of domain 1 (BScope and Purpose^) was
86.8% with low variability (SD = 3.7%). The guideline pub-
lished by ISCD reached the highest score (91.7% = good),
while ACR-SPR-SSR conjoined guideline achieved a score
of 81.9%, which is still considered Bgood^.
For domain 2 (BStakeholder Involvement^), the overall
mean score was Bacceptable^ with a mean score of 71.5%.
Quality scores variability was low (SD = 3.6%). Again,
ISCD Official Positions was the guideline with the highest
score (76.4% = acceptable), while both ACR and
ACR-SPR-SSR guidelines scored the lowest value
(68.1% = acceptable).
Domain 3 (BRigor of Development^) had the
second-lowest mean score (63.9%) with a slightly higher var-
iability (SD = 6.8%) compared to domain 1 and 2. ISCD
Official Positions was the guideline with the highest score
(78.6% = acceptable), while Canadian Guideline had the low-
est score (57.3% = low).
Domain 4 (BClar i ty of Presentat ion^) had the
second-highest mean quality score (80.6%), with 9.3% SD.
Guideline scores ranged from 90.3% (good) of ISCD Official
Positions to 66.7% (acceptable) of the ACR-SPR-SSR
Guideline.
Total mean score of domain 5 (BApplicability^) was 70.6%
with intermediate variability (SD = 6.8%). Within this do-
main, ISCD had the highest score (78.1% = acceptable) while
t h e ACR-SPR -SSR Gu i d e l i n e h ad t h e l owe s t
(61.5% = acceptable).
The lowest scores were obtained by domain 6 (BEditorial
Independence^), with a total mean score of 54.7%; this do-
main had also the larger variability, with 12.5% SD. The
guideline published by the Canadian Association of
Radiologists reached the better score (75% = acceptable); dif-
ferently from the previous domain, the ISCD Official
Positions had the lowest domain score (41.7% = low).
Interobserver variability ranges were 0.702 (good; 95%
confidence interval, 0.438–0.860) for the ISCD guidelines,
0.230 (fair; −0.454-0.639) for the ACR-SPR-SSR guideline,
0.451 (moderate; −0.037-0.743) for the Canadian Association
of Radiologists guideline and 0.474 (moderate; −0.006-0.753)
for the ACR guideline.
Discussion
Our main finding is that the AGREE II appraisal of the DXA
guidelines showed satisfactory results as the overall quality
was high in three out of four guidelines and that the domain
Table 2 General characteristics of DXA guidelines included in the
analysis
DXA guideline title Country
of origin
Year of
publication
Organisation
Recommendations for
Bone Mineral
Density Reporting in
Canada [8]
Canada 2005 Canadian Association
of Radiologists
International Society
for Clinical
Densitometry 2007
Adult and Pediatric
Official Positions [7]
USA 2008 International Society
for Clinical
Densitometry
ACR Appropriateness
Criteria:
Osteoporosis and
Bone Mineral
Density [10]
USA 2010 American College of
Radiology (ACR)
ACR-SPR-SSR
Practice Parameter
for the Performance
of Dual-Energy
X-Ray
Absorptiometry [9]
USA 2014 American College of
Radiology (ACR),
Society for Pediatric
Radiology (SPR),
Society of Skeletal
Radiology (SSR)
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score never decreased under 40%. However, a wide variability
was found across the six domains, with scores that ranged
from Bgood^ to Blow^ in all guidelines. Results were some-
how uniform when considering the within-domain scores;
among these, domain 1 scored all Bgood^ percentages with
low variability, which means that the scope and purpose of all
the evaluated guidelines was well described.
Domains with the highest quality were BScope and
Purpose^ and BClarity of Presentation^; both scored over
80%. This finding is comparable to different previous guide-
line evaluation studies with the AGREE II instrument, regard-
less of the topic [18–21]. The reason for such high scores
regardless of the topic is not clear [18]. This may be attribut-
able to the fact that both domains 1 and 3 contain fundamental
elements that cannot be easily omitted, such as guideline ob-
jectives, the health question to deal with and the population to
whom the guideline is applied.
Editorial independence (domain 6) scored low in all guide-
lines with the exception of the BRecommendations for BMD
Reporting in Canada^. Thus, this was our poorest scoring
domain (54.7%). Armstrong et al. reported similar results
(45%) after conducting an evaluation of osteoporosis guide-
lines focusing on physical activity and safe movement [18].
This domain scored low in several other studies [19, 20, 22,
23], with few exceptions [21]. According to AGREE II, the
evaluation of Beditorial independence^ considers two aspects
related to funding bodies or potential authors’ competing in-
terests that may influence the guideline content. An explicit
statement that the funding body interests have not influenced
the final recommendations should be present; at the same
time, all guideline authors should provide a disclosure of all
competing interests. This information is not reported clearly in
these guidelines, in particular for ISCD Official Positions, a
paper that scored very well for the remaining domains. This is
a critical aspect, as it has been shown that conflicts of interest
among authors of such guidelines are very common and may
affect the quality of final recommendations [18, 24–26].
Therefore, high quality for this domain is particularly needed,
especially for those guidelines with recommendations on di-
agnostic technologies or medications.
When considering the quality of DXA guidelines over
time, we observed a decrease of the overall scores. The
ACR-SPR-SSR guideline, published in 2014, had a score low-
er than 8.4% of the guideline issued in 2005 by the Canadian
Association of Radiologists. This finding is in accordance
with a review published in 2012 by Kung et al., which found
no clear improvement of guideline quality over the past 2
decades [27]. Conversely, Armstrong et al. found quality im-
provement over time [18]. The limited number of studies we
included in our review may perhaps explain our different
results.
One issue of this analysis, whichmay be seen as a limitation,
is that interobserver reproducibility was low, except for theTa
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ISCD guideline. Analysing the scores and the comments provid-
ed by the reviewers in detail, the highest variability was found for
the Applicability and Editorial Independence domains. Regarding
applicability, some reviewers found that information was not
clearly presented, while others considered them implicit in the
provided statements. Regarding Editorial Independence, we note
that in most cases information about funding and competing in-
terests were provided in documents/links separated from themain
paper. Thus, some reviewers considered that the information was
not present, while others browsed the additional documents to
find it. These data mean that, despite previous training, reviewers
had different interpretations of the same items: some were very
adherent to what stated by the AGREE II, while others had a
broader interpretation. Of note, a wide range of interobserver
variability (0.34 to 0.65) was also reported in a previous paper
that used the same tool to evaluate osteoporosis clinical practice
guidelines for physical activity and safe movement [18].
Some limitations of this study are intrinsic to the AGREE
II, as this instrument is not aimed to evaluate all aspects of a
guideline. In particular, AGREE II does not evaluate the de-
gree of consistency between the guideline recommendations
and the reported evidence [19]. Also, AGREE II does not
specifically evaluate the clinical content, a limitation that is
common to several appraisal tools [28]. Then, the four re-
viewers of this work have different experience in DXA and
guideline evaluation, potentially biasing the outcome.
However, the use of average scores and previous training on
the proper use of the AGREE II instrument may have reduced
the impact of this limitation. Last, as mentioned above, the
number of DXA guidelines included in the evaluation is small.
In conclusion, evidence-based guidelines are of vital im-
portance to provide valuable suggestions to physicians in the
daily clinical practice. Our study showed that the overall qual-
ity of the DXA guidelines is satisfactory according to the
AGREE II evaluation instrument. The domain of BEditorial
Independence^ was the most critical one in terms of overall
score; thus emphasis should be given to these aspects in order
to provide unbiased recommendations. When developing fu-
ture guidelines, authors should also take this domain into ac-
count as it may bring clinical consequences.
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